Implementation of a Multi-Disciplinary Team and Quality of Goals of Care Discussions in Palliative Surgical Oncology Patients.


Journal

Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 15 05 2023
accepted: 24 07 2023
medline: 8 11 2023
pubmed: 6 9 2023
entrez: 6 9 2023
Statut: ppublish

Résumé

Palliative surgical oncology patients represent a unique group with complex needs who often require multidisciplinary input for the provision of timely and holistic care. The authors assembled a multi-disciplinary palliative intervention team and evaluated its association with the quality of discussions on goals of care (GOC) among advanced cancer patients undergoing palliative interventions. This prospective cohort study analyzed advanced cancer patients undergoing palliative interventions at a single urban academic center from October 2019 to March 2022. In January 2021, a multi-disciplinary palliative surgical intervention (MD-PALS) team was assembled. All palliative surgical oncology patients were discussed at multi-disciplinary meetings and managed by members of the MD-PALS team. An interrupted time series (ITS) model was built to evaluate the association of MD-PALS implementation and the quality of GOC discussions as measured by a consensus-derived four-point GOC discussion quality score. The study recruited 126 palliative surgical oncology patients: 44 in the pre-MD-PALS group and 82 in the post-MD-PALS group. The two groups did not differ significantly in baseline demographics, treatment, or postoperative and survival outcomes. Compared with the pre-MD-PALS group, the post-MD-PALS group had a significantly higher mean GOC discussion quality score (1.34 vs 2.61; p < 0.001). Based on the ITS model, the average quarterly GOC discussion quality score increased significantly among patients after implementation of the MD-PALS team (change = 1.93; 95 % confidence interval, 0.96-2.90; P = 0.003). The implementation of an MD-PALS team was associated with improvements in the quality of GOC discussions among palliative surgical oncology patients.

Sections du résumé

BACKGROUND BACKGROUND
Palliative surgical oncology patients represent a unique group with complex needs who often require multidisciplinary input for the provision of timely and holistic care. The authors assembled a multi-disciplinary palliative intervention team and evaluated its association with the quality of discussions on goals of care (GOC) among advanced cancer patients undergoing palliative interventions.
METHODS METHODS
This prospective cohort study analyzed advanced cancer patients undergoing palliative interventions at a single urban academic center from October 2019 to March 2022. In January 2021, a multi-disciplinary palliative surgical intervention (MD-PALS) team was assembled. All palliative surgical oncology patients were discussed at multi-disciplinary meetings and managed by members of the MD-PALS team. An interrupted time series (ITS) model was built to evaluate the association of MD-PALS implementation and the quality of GOC discussions as measured by a consensus-derived four-point GOC discussion quality score.
RESULTS RESULTS
The study recruited 126 palliative surgical oncology patients: 44 in the pre-MD-PALS group and 82 in the post-MD-PALS group. The two groups did not differ significantly in baseline demographics, treatment, or postoperative and survival outcomes. Compared with the pre-MD-PALS group, the post-MD-PALS group had a significantly higher mean GOC discussion quality score (1.34 vs 2.61; p < 0.001). Based on the ITS model, the average quarterly GOC discussion quality score increased significantly among patients after implementation of the MD-PALS team (change = 1.93; 95 % confidence interval, 0.96-2.90; P = 0.003).
CONCLUSION CONCLUSIONS
The implementation of an MD-PALS team was associated with improvements in the quality of GOC discussions among palliative surgical oncology patients.

Identifiants

pubmed: 37672144
doi: 10.1245/s10434-023-14190-z
pii: 10.1245/s10434-023-14190-z
pmc: PMC10625938
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8054-8060

Subventions

Organisme : National Cancer Centre of Singapore
ID : CIRG21jun-0038

Informations de copyright

© 2023. The Author(s).

Références

Am J Med. 2000 Oct 15;109(6):469-75
pubmed: 11042236
J Infect Public Health. 2021 Nov;14(11):1635-1641
pubmed: 34627058
Surgeon. 2021 Feb;19(1):e20-e27
pubmed: 32807661
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Acad Med. 2006 Nov;81(11):1008-12
pubmed: 17065871
Ann Surg Open. 2022 Sep 26;3(4):e206
pubmed: 37600285
J Gastrointest Surg. 2020 Aug;24(8):1852-1859
pubmed: 32347453
Semin Oncol Nurs. 2005 Feb;21(1):44-52
pubmed: 15807056
J Pain Symptom Manage. 2022 Jan;63(1):e29-e36
pubmed: 34271146
Surg Clin North Am. 2011 Apr;91(2):343-53, viii
pubmed: 21419257
Ann Surg Oncol. 2022 Nov;29(12):7281-7292
pubmed: 35947309
Mayo Clin Proc. 2017 Feb;92(2):280-286
pubmed: 28160875
Surg Oncol. 2011 Sep;20(3):163-8
pubmed: 20719499
Ann Surg. 2022 Jan 1;275(1):196-202
pubmed: 32502076
J Pain Symptom Manage. 2017 Sep;54(3):417-425
pubmed: 28782701
JAMA. 2013 Dec 4;310(21):2271-81
pubmed: 24302090
Lancet Oncol. 2018 Mar;19(3):394-404
pubmed: 29402701
Palliat Med. 2008 Jun;22(4):365-75
pubmed: 18541641
J Am Coll Radiol. 2020 Jul;17(7):873-877
pubmed: 32425709
J Natl Compr Canc Netw. 2016 Apr;14(4):439-45
pubmed: 27059192
Arch Intern Med. 2007 Mar 12;167(5):453-60
pubmed: 17353492
Ann Surg. 2018 May;267(5):823-825
pubmed: 29112003
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542

Auteurs

Joel J Y Soon (JJY)

Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore.

Darryl W K Juan (DWK)

Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore.

Whee S Ong (WS)

Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore.

Schin Bek (S)

Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Patricia S H Neo (PSH)

Division of Supportive and Palliative Care, National Cancer Centre Singapore, Singapore, Singapore.

Ennaliza Salazar (E)

Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore, Singapore.

Kun Da Zhuang (K)

Vascular and Interventional Radiology, Singapore General Hospital, Singapore, Singapore.

Yee Pin Tan (YP)

Department of Psychosocial Oncology, National Cancer Centre Singapore, Singapore, Singapore.

Chin Jin Seo (CJ)

Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore.
Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore.

Johnny C A Ong (JCA)

Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore.
Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore.
Duke-NUS Medical School, SingHealth Duke-NUS Oncology Academic Clinical Program, Singapore, Singapore.
Duke-NUS Medical School, SingHealth Duke-NUS Surgery Academic Clinical Program, Singapore, Singapore.
Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore.
Institute of Molecular and Cell Biology, A*STAR Research Entities, Singapore, Singapore.

Claramae S Chia (CS)

Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore.
Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore.
Duke-NUS Medical School, SingHealth Duke-NUS Oncology Academic Clinical Program, Singapore, Singapore.

Jolene S M Wong (JSM)

Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore. jolene.wong.s.m@singhealth.com.sg.
Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore. jolene.wong.s.m@singhealth.com.sg.
Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore. jolene.wong.s.m@singhealth.com.sg.
Duke-NUS Medical School, SingHealth Duke-NUS Oncology Academic Clinical Program, Singapore, Singapore. jolene.wong.s.m@singhealth.com.sg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH